BioMarin Pharmaceutical Inc. - Financial and Strategic Analysis Review

Summary

BioMarin Pharmaceutical Inc. - Financial and Strategic Analysis Review

BioMarin Pharmaceutical Inc. (BioMarin) is principally engaged in the development and commercialization of innovative biopharmaceuticals for serious diseases and medical conditions. BioMarin's product portfolio includes three approved products namely Naglazyme, Aldurazyme, and Kuvan. The company is headquartered at California, United States.

Global Markets Direct's BioMarin Pharmaceutical Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of BioMarin Pharmaceutical Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • History
  • SWOT Analysis
  • SWOT Analysis - Overview
  • BioMarin Pharmaceutical Inc. - Strengths
  • BioMarin Pharmaceutical Inc. - Strengths - Collaborative Agreements
  • BioMarin Pharmaceutical Inc. - Strengths - Market Position of Naglazyme and Aldurazyme
  • BioMarin Pharmaceutical Inc. - Strengths - Strong Development Pipeline
  • BioMarin Pharmaceutical Inc. - Weaknesses
  • BioMarin Pharmaceutical Inc. - Weaknesses - Single Manufacturing Facility
  • BioMarin Pharmaceutical Inc. - Weaknesses - Increased SG&A Expenses
  • BioMarin Pharmaceutical Inc. - Weaknesses - Dependence on Limited Customers
  • BioMarin Pharmaceutical Inc. - Opportunities
  • BioMarin Pharmaceutical Inc. - Opportunities - Product Approvals
  • BioMarin Pharmaceutical Inc. - Opportunities - Licensing Agreement
  • BioMarin Pharmaceutical Inc. - Opportunities - Diversification of Geographic Coverage
  • BioMarin Pharmaceutical Inc. - Opportunities - Rising Healthcare Expenditure in the US
  • BioMarin Pharmaceutical Inc. - Threats
  • BioMarin Pharmaceutical Inc. - Threats - Competition in the Drug Development
  • BioMarin Pharmaceutical Inc. - Threats - Corresponding Third Party Patents
  • BioMarin Pharmaceutical Inc. - Threats - Industry Consolidation
  • BioMarin Pharmaceutical Inc. - Threats - Increased Pricing Control
  • BioMarin Pharmaceutical Inc. - Threats - Impact of the Financial Crisis
  • BioMarin Pharmaceutical Inc. - Threats - Tightening of the FDA's Regulatory Oversight
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Locations And Subsidiaries - Head Office
  • Locations And Subsidiaries - Other Locations & Subsidiaries
  • Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • BioMarin Pharmaceutical Inc., Key Facts
  • Major Products and Services
  • BioMarin Pharmaceutical Inc., History
  • BioMarin Pharmaceutical Inc., Key Employees
  • BioMarin Pharmaceutical Inc., Key Employee Biographies
  • BioMarin Pharmaceutical Inc., Other Locations
  • BioMarin Pharmaceutical Inc., Ratios based on current share price
  • BioMarin Pharmaceutical Inc., Annual Ratios
  • BioMarin Pharmaceutical Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • BioMarin Pharmaceutical Inc., Ratio Charts